Pyridine → HCID 19369246, compound
Reaction equation
N1CCCCC1[CH2:7][CH2:8][CH:9]1[NH:15][C:14](=[O:16])[CH2:13][CH2:12][CH2:11][CH2:10]1.[CH3:17][S:18](Cl)(=[O:20])=[O:19].[N:22]1[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=1>C(Cl)Cl>[CH3:17][S:18]([CH:23]1[CH2:24][CH2:25][CH2:26][CH2:27][N:22]1[CH2:7][CH2:8][CH:9]1[NH:15][C:14](=[O:16])[CH2:13][CH2:12][CH2:11][CH2:10]1)(=[O:20])=[O:19]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
Example 296 B) To the hexahydro-7-[2-(2-piperidyl) ethyl]-1H-azepin-2-one product of Example 296 A (2-3 g, 10 mmol) in anhydrous pyridine (8 mL) and CH2Cl2 (4 mL) was added dropwise methanesulfonyl chloride (0.74 mL) in CH2Cl2 (2 mL). The contents were stirred overnight, concentrated in vacuo and partitioned between CH2Cl2 and water. The CH2Cl2 layer was dried over MgSO4 and concentrated in vacuo leaving an oil. The oil was purified by C18 reverse phase chromatography eluding with a CH3CN/H2O (0.05% TFA) gradient to give hexahydro-7-[2-(2-methylsulfonylpiperidyl)ethyl]-1H-azepin-2-one (1.5 g).
Workup
- concentrationconcentrated in vacuo
- custompartitioned between CH2Cl2 and water
- dry with materialThe CH2Cl2 layer was dried over MgSO4
- concentrationconcentrated in vacuo
- customleaving an oil
- customThe oil was purified by C18 reverse phase chromatography
Sources & evidence
- ORD record
- ord-9776bd081c454022b97d9f04b980afff
- Source dataset
- uspto-grants-2000_01
- Patent number
- US06011028
Reaction notes
Loading…